" The reason for this commitment and expansion is because of the  ’s focus on creating better business climate here in the United States," he said. What Mr. Spicer didn’t mention is that Bayer, the German chemical giant, faces intense scrutiny from antitrust regulators in Washington and Europe over its plan to buy Monsanto, based in St. Louis, for $57 billion. If Bayer cannot win approval from the Justice Department and the Federal Trade Commission, it will be costly, with Bayer obligated to pay Monsanto $2 billion under the deal’s terms. 